{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:11:25Z","timestamp":1790644285719,"version":"4.1.0"},"reference-count":16,"publisher":"Japanese Society of Veterinary Science","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1292\/jvms.24-0432","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:09:22Z","timestamp":1743790162000},"page":"541-545","source":"Crossref","is-referenced-by-count":3,"title":["A case of lingual lymphoma in a dog treated with oclacitinib"],"prefix":"10.1292","volume":"87","author":[{"given":"Shohei","family":"NISHIMORI","sequence":"first","affiliation":[{"name":"Jiyugaoka Animal Clinic, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"OKANO","sequence":"additional","affiliation":[{"name":"Japan Veterinary Advanced Medical Center, Kawasaki Main Hospital, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"NIBE","sequence":"additional","affiliation":[{"name":"Fujifilm VET Systems, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"IGASE","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan"},{"name":"Division of Translational Research for One Medicine, Research Institute for Cell Design Medical Science, Yamaguchi University, Yamaguchi, Japan"},{"name":"Japan Small Animal Cancer Center, Affiliated with the Japan Small Animal Medical Center Foundation, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"MIZUNO","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Diagnostics and Therapeutics, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan"},{"name":"Division of Translational Research for One Medicine, Research Institute for Cell Design Medical Science, Yamaguchi University, Yamaguchi, Japan"},{"name":"Japan Small Animal Cancer Center, Affiliated with the Japan Small Animal Medical Center Foundation, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Aslan J, Shipstone MA, Sullivan LM.  2021. Treatment of canine cutaneous epitheliotropic T-cell lymphoma with oclacitinib: a case report. <i>Vet Dermatol<\/i> 32: 398\u2013e113 .","DOI":"10.1111\/vde.12976"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR. Cancer Genome Project. 2005. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. <i>Lancet<\/i> 365: 1054\u20131061.","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cosgrove SB, Cleaver DM, King VL, Gilmer AR, Daniels AE, Wren JA, Stegemann MR.  2015. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. <i>Vet Dermatol<\/i> 26: 171\u2013179, e35.","DOI":"10.1111\/vde.12194"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Culp WTN, Ehrhart N, Withrow SJ, Rebhun RB, Boston S, Buracco P, Reiter AM, Schallberger SP, Aldridge CF, Kent MS, Mayhew PD, Brown DC.  2013. Results of surgical excision and evaluation of factors associated with survival time in dogs with lingual neoplasia: 97 cases (1995\u20132008). <i>J Am Vet Med Assoc<\/i> 242: 1392\u20131397.","DOI":"10.2460\/javma.242.10.1392"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Delhommeau F, Dupont S, Tonetti C, Mass\u00e9 A, Godin I, Le Couedic JP, Debili N, Saulnier P, Casadevall N, Vainchenker W, Giraudier S.  2007. Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis. <i>Blood<\/i> 109: 71\u201377.","DOI":"10.1182\/blood-2006-03-007146"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Harris LJ, Rout ED, Hughes KL, Labadie JD, Boostrom B, Yoshimoto JA, Cannon CM, Avery PR, Ehrhart EJ, Avery AC.  2018. Clinicopathologic features of lingual canine T-zone lymphoma. <i>Vet Comp Oncol<\/i> 16: 131\u2013139.","DOI":"10.1111\/vco.12322"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Jasiecka-Miko\u0142ajczyk A, Jaroszewski JJ, Ma\u015blanka T.  2018. Oclacitinib depletes canine CD4<sup>+<\/sup> and CD8<sup>+<\/sup> T cells in vitro. <i>Res Vet Sci<\/i> 121: 124\u2013129 .","DOI":"10.1016\/j.rvsc.2018.10.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC.  2005. A gain-of-function mutation of JAK2 in myeloproliferative disorders. <i>N Engl J Med<\/i> 352: 1779\u20131790.","DOI":"10.1056\/NEJMoa051113"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kubo S, Nakayamada S, Tanaka Y.  2023. JAK inhibitors for rheumatoid arthritis. <i>Expert Opin Investig Drugs<\/i> 32: 333\u2013344.","DOI":"10.1080\/13543784.2023.2199919"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mizutani N, Goto-Koshino Y, Takahashi M, Uchida K, Tsujimoto H.  2016. Clinical and histopathological evaluation of 16 dogs with T-zone lymphoma. <i>J Vet Med Sci<\/i> 78: 1237\u20131244.","DOI":"10.1292\/jvms.15-0688"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. P\u00e9rez-Rivero G, Cascio G, Soriano SF, Sanz \u00c1G, de Guinoa JS, Rodr\u00edguez-Frade JM, Gomariz RP, Holgado BL, Caba\u00f1as C, Carrasco YR, Stein JV, Mellado M.  2013. Janus kinases 1 and 2 regulate chemokine-mediated integrin activation and na\u00efve T-cell homing. <i>Eur J Immunol<\/i> 43: 1745\u20131757.","DOI":"10.1002\/eji.201243178"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Simpson AC, Schissler JR, Rosychuk RAW, Moore AR.  2017. The frequency of urinary tract infection and subclinical bacteriuria in dogs with allergic dermatitis treated with oclacitinib: a prospective study. <i>Vet Dermatol<\/i> 28: 485\u2013e113.","DOI":"10.1111\/vde.12450"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tashkandi H, Younes IE.  2024. Advances in molecular understanding of polycythemia vera, essential thrombocythemia, and primary myelofibrosis: towards precision medicine. <i>Cancers (Basel)<\/i> 16: 16.","DOI":"10.3390\/cancers16091679"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tefferi A.  2008. JAK and MPL mutations in myeloid malignancies. <i>Leuk Lymphoma<\/i> 49: 388\u2013397.","DOI":"10.1080\/10428190801895360"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Xiang Z, Zhao Y, Mitaksov V, Fremont DH, Kasai Y, Molitoris A, Ries RE, Miner TL, McLellan MD, DiPersio JF, Link DC, Payton JE, Graubert TA, Watson M, Shannon W, Heath SE, Nagarajan R, Mardis ER, Wilson RK, Ley TJ, Tomasson MH.  2008. Identification of somatic JAK1 mutations in patients with acute myeloid leukemia. <i>Blood<\/i> 111: 4809\u20134812.","DOI":"10.1182\/blood-2007-05-090308"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, Bao Z, Lu J, Li L.  2023. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. <i>Signal Transduct Target Ther<\/i> 8: 204.","DOI":"10.1038\/s41392-023-01468-7"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/5\/87_24-0432\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T23:33:27Z","timestamp":1747438407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/5\/87_24-0432\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.24-0432","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"24-0432"}}